Literature DB >> 2179763

Electrodiagnostic features of the Guillain-Barré syndrome: the relative sensitivity of different techniques.

R K Olney1, M J Aminoff.   

Abstract

We compared the diagnostic sensitivity of somatosensory evoked potentials (SEPs) and F waves with peripheral motor and sensory nerve conduction studies in 15 patients with the Guillain-Barré syndrome. All 4 types of studies were performed on 44 nerves (17 median, 12 ulnar, and 15 lower extremity). In the lower extremities, we used the peroneal nerves for all types of study except peripheral sensory conduction studies, which were performed on the sural nerve. We detected abnormalities by peripheral motor conduction studies in 33 of 44 nerves, by F waves in 31, by SEPs in 23, and by peripheral sensory conduction in 17. The cumulative sensitivity increased with the testing of multiple nerves by motor nerve conduction, sensory nerve conduction, and F-wave studies, but not with multiple SEPs. F-wave studies were significantly more sensitive than SEPs in identifying abnormalities. Thus, the recording of SEPs is indicated for diagnosis of the Guillain-Barré syndrome only if peripheral nerve conduction and F-wave studies are normal.

Entities:  

Mesh:

Year:  1990        PMID: 2179763     DOI: 10.1212/wnl.40.3_part_1.471

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Excitability and recruitment patterns of spinal motoneurons in human sleep as assessed by F-wave recordings.

Authors:  Farid Salih; Saskia Steinheimer; Pascal Grosse
Journal:  Exp Brain Res       Date:  2011-06-30       Impact factor: 1.972

2.  Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.

Authors:  S Kuwabara; K Ogawara; K Mizobuchi; M Koga; M Mori; T Hattori; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

Review 3.  Investigation of peripheral neuropathy.

Authors:  J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.